{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:19:23Z","timestamp":1791314363378,"version":"4.3.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,13]],"date-time":"2014-01-13T00:00:00Z","timestamp":1389571200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-16","type":"journal-article","created":{"date-parts":[[2014,1,13]],"date-time":"2014-01-13T12:27:37Z","timestamp":1389616057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Rajesh","family":"Thangapazham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Katta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyh-Han","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Petrovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Dobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,13]]},"reference":[{"issue":"17","key":"4249_CR1","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.1073\/pnas.84.17.6131","volume":"84","author":"ES Reddy","year":"1987","unstructured":"Reddy ES, Rao VN, Papas TS: The erg gene: a human gene related to the ets oncogene. Proc Natl Acad Sci USA. 1987, 84 (17): 6131-6135. 10.1073\/pnas.84.17.6131.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"4249_CR2","first-page":"254","volume":"5","author":"S Rahim","year":"2013","unstructured":"Rahim S, Uren A: Emergence of ETS transcription factors as diagnostic tools and therapeutic targets in prostate cancer. Am J of Transl Res. 2013, 5 (3): 254-268.","journal-title":"Am J of Transl Res"},{"key":"4249_CR3","volume-title":"Visakorpi T","author":"CE Barbieri","year":"2013","unstructured":"Barbieri CE, Bangma CH, Bjartell A, Catto JW, Culig Z, Gronberg H, Luo J: Visakorpi T. 2013, The Mutational Landscape of Prostate Cancer. European urology: Rubin MA"},{"issue":"3","key":"4249_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s11934-013-0321-1","volume":"14","author":"D Hessels","year":"2013","unstructured":"Hessels D, Schalken JA: Recurrent gene fusions in prostate cancer: their clinical implications and uses. Curr Urol Rep. 2013, 14 (3): 214-222. 10.1007\/s11934-013-0321-1.","journal-title":"Curr Urol Rep"},{"issue":"7","key":"4249_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrc2402","volume":"8","author":"C Kumar-Sinha","year":"2008","unstructured":"Kumar-Sinha C, Tomlins SA, Chinnaiyan AM: Recurrent gene fusions in prostate cancer. Nat Rev Cancer. 2008, 8 (7): 497-511. 10.1038\/nrc2402.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4249_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/aja.2011.145","volume":"14","author":"MA Rubin","year":"2012","unstructured":"Rubin MA: ETS rearrangements in prostate cancer. Asian J of Androl. 2012, 14 (3): 393-399. 10.1038\/aja.2011.145.","journal-title":"Asian J of Androl"},{"issue":"3","key":"4249_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/pcan.2010.23","volume":"13","author":"B Furusato","year":"2010","unstructured":"Furusato B, Tan SH, Young D, Dobi A, Sun C, Mohamed AA, Thangapazham R, Chen Y, McMaster G, Sreenath T, et al: ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification. Prostate cancer and prostatic Dis. 2010, 13 (3): 228-237. 10.1038\/pcan.2010.23.","journal-title":"Prostate cancer and prostatic Dis"},{"issue":"7","key":"4249_CR8","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1593\/neo.10726","volume":"12","author":"K Park","year":"2010","unstructured":"Park K, Tomlins SA, Mudaliar KM, Chiu YL, Esgueva R, Mehra R, Suleman K, Varambally S, Brenner JC, MacDonald T, et al: Antibody-based detection of ERG rearrangement-positive prostate cancer. Neoplasia. 2010, 12 (7): 590-598.","journal-title":"Neoplasia"},{"issue":"17","key":"4249_CR9","first-page":"4180","volume":"59","author":"B Lin","year":"1999","unstructured":"Lin B, Ferguson C, White JT, Wang S, Vessella R, True LD, Hood L, Nelson PS: Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res. 1999, 59 (17): 4180-4184.","journal-title":"Cancer Res"},{"issue":"8","key":"4249_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.steroids.2009.02.007","volume":"74","author":"IU Agoulnik","year":"2009","unstructured":"Agoulnik IU, Weigel NL: Coactivator selective regulation of androgen receptor activity. Steroids. 2009, 74 (8): 669-674. 10.1016\/j.steroids.2009.02.007.","journal-title":"Steroids"},{"issue":"5748","key":"4249_CR11","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, et al: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005, 310 (5748): 644-648. 10.1126\/science.1117679.","journal-title":"Science"},{"issue":"7","key":"4249_CR12","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1158\/0008-5472.CAN-08-3760","volume":"69","author":"JC Pignon","year":"2009","unstructured":"Pignon JC, Koopmansch B, Nolens G, Delacroix L, Waltregny D, Winkler R: Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines. Cancer Res. 2009, 69 (7): 2941-2949. 10.1158\/0008-5472.CAN-08-3760.","journal-title":"Cancer Res"},{"issue":"3","key":"4249_CR13","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1158\/0008-5472.CAN-08-2216","volume":"69","author":"DS Welsbie","year":"2009","unstructured":"Welsbie DS, Xu J, Chen Y, Borsu L, Scher HI, Rosen N, Sawyers CL: Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer. Cancer Res. 2009, 69 (3): 958-966. 10.1158\/0008-5472.CAN-08-2216.","journal-title":"Cancer Res"},{"issue":"2","key":"4249_CR14","first-page":"338","volume":"62","author":"H Chen","year":"2002","unstructured":"Chen H, Nandi AK, Li X, Bieberich CJ: NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter. Cancer Res. 2002, 62 (2): 338-340.","journal-title":"Cancer Res"},{"issue":"6","key":"4249_CR15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1432-0436.2008.00292.x","volume":"76","author":"C Abate-Shen","year":"2008","unstructured":"Abate-Shen C, Shen MM, Gelmann E: Integrating differentiation and cancer: the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Differ; Res in Biol diversity. 2008, 76 (6): 717-727. 10.1111\/j.1432-0436.2008.00292.x.","journal-title":"Differ; Res in Biol diversity"},{"issue":"2","key":"4249_CR16","doi-asserted-by":"publisher","first-page":"e9427","DOI":"10.1371\/journal.pone.0009427","volume":"5","author":"T Iwata","year":"2010","unstructured":"Iwata T, Schultz D, Hicks J, Hubbard GK, Mutton LN, Lotan TL, Bethel C, Lotz MT, Yegnasubramanian S, Nelson WG, et al: MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells. PloS one. 2010, 5 (2): e9427-10.1371\/journal.pone.0009427.","journal-title":"PloS one"},{"issue":"5","key":"4249_CR17","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1073\/pnas.042688999","volume":"99","author":"MJ Kim","year":"2002","unstructured":"Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM, Abate-Shen C: Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA. 2002, 99 (5): 2884-2889. 10.1073\/pnas.042688999.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"4249_CR18","first-page":"3886","volume":"63","author":"C Abate-Shen","year":"2003","unstructured":"Abate-Shen C, Banach-Petrosky WA, Sun X, Economides KD, Desai N, Gregg JP, Borowsky AD, Cardiff RD, Shen MM: Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res. 2003, 63 (14): 3886-3890.","journal-title":"Cancer Res"},{"issue":"37","key":"4249_CR19","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1038\/onc.2009.181","volume":"28","author":"H Song","year":"2009","unstructured":"Song H, Zhang B, Watson MA, Humphrey PA, Lim H, Milbrandt J: Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Oncogene. 2009, 28 (37): 3307-3319. 10.1038\/onc.2009.181.","journal-title":"Oncogene"},{"issue":"8","key":"4249_CR20","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1158\/0008-5472.CAN-09-3138","volume":"70","author":"C Bowen","year":"2010","unstructured":"Bowen C, Gelmann EP: NKX3.1 activates cellular response to DNA damage. Cancer Res. 2010, 70 (8): 3089-3097. 10.1158\/0008-5472.CAN-09-3138.","journal-title":"Cancer Res"},{"issue":"5","key":"4249_CR21","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1172\/JCI58540","volume":"122","author":"PD Anderson","year":"2012","unstructured":"Anderson PD, McKissic SA, Logan M, Roh M, Franco OE, Wang J, Doubinskaia I, van der Meer R, Hayward SW, Eischen CM, et al: Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. The J of Clin Invest. 2012, 122 (5): 1907-1919. 10.1172\/JCI58540.","journal-title":"The J of Clin Invest"},{"issue":"40","key":"4249_CR22","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1038\/onc.2008.183","volume":"27","author":"C Sun","year":"2008","unstructured":"Sun C, Dobi A, Mohamed A, Li H, Thangapazham RL, Furusato B, Shaheduzzaman S, Tan SH, Vaidyanathan G, Whitman E, et al: TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. Oncogene. 2008, 27 (40): 5348-5353. 10.1038\/onc.2008.183.","journal-title":"Oncogene"},{"issue":"30","key":"4249_CR23","doi-asserted-by":"publisher","first-page":"12465","DOI":"10.1073\/pnas.0905931106","volume":"106","author":"Y Zong","year":"2009","unstructured":"Zong Y, Xin L, Goldstein AS, Lawson DA, Teitell MA, Witte ON: ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. Proc Natl Acad Sci USA. 2009, 106 (30): 12465-12470. 10.1073\/pnas.0905931106.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"4249_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/ng.371","volume":"41","author":"JC King","year":"2009","unstructured":"King JC, Xu J, Wongvipat J, Hieronymus H, Carver BS, Leung DH, Taylor BS, Sander C, Cardiff RD, Couto SS, et al: Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis. Nat Genet. 2009, 41 (5): 524-526. 10.1038\/ng.371.","journal-title":"Nat Genet"},{"issue":"5","key":"4249_CR25","doi-asserted-by":"publisher","first-page":"e10547","DOI":"10.1371\/journal.pone.0010547","volume":"5","author":"P Kunderfranco","year":"2010","unstructured":"Kunderfranco P, Mello-Grand M, Cangemi R, Pellini S, Mensah A, Albertini V, Malek A, Chiorino G, Catapano CV, Carbone GM: ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer. PloS one. 2010, 5 (5): e10547-10.1371\/journal.pone.0010547.","journal-title":"PloS one"},{"issue":"3","key":"4249_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/geno.1997.4845","volume":"44","author":"A Paoloni-Giacobino","year":"1997","unstructured":"Paoloni-Giacobino A, Chen H, Peitsch MC, Rossier C, Antonarakis SE: Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics. 1997, 44 (3): 309-320. 10.1006\/geno.1997.4845.","journal-title":"Genomics"},{"issue":"4815","key":"4249_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1126\/science.3299708","volume":"237","author":"VN Rao","year":"1987","unstructured":"Rao VN, Papas TS, Reddy ES: erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation. Science. 1987, 237 (4815): 635-639. 10.1126\/science.3299708.","journal-title":"Science"},{"key":"4249_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.gene.2003.09.047","volume":"324","author":"CM Owczarek","year":"2004","unstructured":"Owczarek CM, Portbury KJ, Hardy MP, O'Leary DA, Kudoh J, Shibuya K, Shimizu N, Kola I, Hertzog PJ: Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16. Gene. 2004, 324: 65-77.","journal-title":"Gene"},{"issue":"15","key":"4249_CR29","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1158\/1078-0432.CCR-08-0531","volume":"14","author":"Y Hu","year":"2008","unstructured":"Hu Y, Dobi A, Sreenath T, Cook C, Tadase AY, Ravindranath L, Cullen J, Furusato B, Chen Y, Thangapazham RL, et al: Delineation of TMPRSS2-ERG splice variants in prostate cancer. Clin cancer Res: an Off J of the Am Assoc for Cancer Res. 2008, 14 (15): 4719-4725. 10.1158\/1078-0432.CCR-08-0531.","journal-title":"Clin cancer Res: an Off J of the Am Assoc for Cancer Res"},{"issue":"3","key":"4249_CR30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.molcel.2007.05.041","volume":"27","author":"Q Wang","year":"2007","unstructured":"Wang Q, Li W, Liu XS, Carroll JS, Janne OA, Keeton EK, Chinnaiyan AM, Pienta KJ, Brown M: A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol cell. 2007, 27 (3): 380-392. 10.1016\/j.molcel.2007.05.041.","journal-title":"Mol cell"},{"issue":"2","key":"4249_CR31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/ng1001-105","volume":"29","author":"T Werner","year":"2001","unstructured":"Werner T: The promoter connection. Nat Genet. 2001, 29 (2): 105-106. 10.1038\/ng1001-105.","journal-title":"Nat Genet"},{"issue":"1","key":"4249_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1073\/pnas.0902001107","volume":"107","author":"RP McMullin","year":"2010","unstructured":"McMullin RP, Dobi A, Mutton LN, Orosz A, Maheshwari S, Shashikant CS, Bieberich CJ: A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland. Proc Natl Acad Sci USA. 2010, 107 (1): 98-103. 10.1073\/pnas.0902001107.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"4249_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11568-007-9004-7","volume":"1","author":"M Zhan","year":"2007","unstructured":"Zhan M: Deciphering modular and dynamic behaviors of transcriptional networks. Genomic Med. 2007, 1 (1\u20132): 19-28.","journal-title":"Genomic Med"},{"issue":"13","key":"4249_CR34","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/bioinformatics\/bti473","volume":"21","author":"K Cartharius","year":"2005","unstructured":"Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T: MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics. 2005, 21 (13): 2933-2942. 10.1093\/bioinformatics\/bti473.","journal-title":"Bioinformatics"},{"issue":"4","key":"4249_CR35","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jmb.2005.09.009","volume":"353","author":"K Masuda","year":"2005","unstructured":"Masuda K, Werner T, Maheshwari S, Frisch M, Oh S, Petrovics G, May K, Srikantan V, Srivastava S, Dobi A: Androgen receptor binding sites identified by a GREF_GATA model. J of mMol Biol. 2005, 353 (4): 763-771. 10.1016\/j.jmb.2005.09.009.","journal-title":"J of mMol Biol"},{"issue":"9","key":"4249_CR36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrg3207","volume":"13","author":"F Spitz","year":"2012","unstructured":"Spitz F, Furlong EE: Transcription factors: from enhancer binding to developmental control. Nature reviews Genetics. 2012, 13 (9): 613-626. 10.1038\/nrg3207.","journal-title":"Nature reviews Genetics"},{"issue":"2","key":"4249_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/molehr\/gal009","volume":"12","author":"S Hihnala","year":"2006","unstructured":"Hihnala S, Kujala M, Toppari J, Kere J, Holmberg C, Hoglund P: Expression of SLC26A3, CFTR and NHE3 in the human male reproductive tract: role in male subfertility caused by congenital chloride diarrhoea. Mol human Reprod. 2006, 12 (2): 107-111. 10.1093\/molehr\/gal009.","journal-title":"Mol human Reprod"},{"issue":"2","key":"4249_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1128\/MCB.05958-11","volume":"32","author":"PY Tan","year":"2012","unstructured":"Tan PY, Chang CW, Chng KR, Wansa KD, Sung WK, Cheung E: Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival. Mol and cell Biol. 2012, 32 (2): 399-414. 10.1128\/MCB.05958-11.","journal-title":"Mol and cell Biol"},{"issue":"9","key":"4249_CR39","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1158\/0008-5472.CAN-12-1342","volume":"73","author":"L Burkhardt","year":"2013","unstructured":"Burkhardt L, Fuchs S, Krohn A, Masser S, Mader M, Kluth M, Bachmann F, Huland H, Steuber T, Graefen M, et al: CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. Cancer Res. 2013, 73 (9): 2795-2805. 10.1158\/0008-5472.CAN-12-1342.","journal-title":"Cancer Res"},{"issue":"5","key":"4249_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ccr.2006.03.031","volume":"9","author":"Q Lei","year":"2006","unstructured":"Lei Q, Jiao J, Xin L, Chang CJ, Wang S, Gao J, Gleave ME, Witte ON, Liu X, Wu H: NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. Cancer cell. 2006, 9 (5): 367-378. 10.1016\/j.ccr.2006.03.031.","journal-title":"Cancer cell"},{"issue":"1","key":"4249_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1042\/BJ20130012","volume":"453","author":"LN Song","year":"2013","unstructured":"Song LN, Bowen C, Gelmann EP: Structural and functional interactions of the prostate cancer suppressor protein NKX3.1 with topoisomerase I. The Biochem J. 2013, 453 (1): 125-136. 10.1042\/BJ20130012.","journal-title":"The Biochem J"},{"issue":"1","key":"4249_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2867-13-4","volume":"13","author":"T Eide","year":"2013","unstructured":"Eide T, Ramberg H, Glackin C, Tindall D, Tasken KA: TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells. Cancer cell Int. 2013, 13 (1): 4-10.1186\/1475-2867-13-4.","journal-title":"Cancer cell Int"},{"issue":"2","key":"4249_CR43","doi-asserted-by":"publisher","first-page":"e4664","DOI":"10.1371\/journal.pone.0004664","volume":"4","author":"N Vij","year":"2009","unstructured":"Vij N, Mazur S, Zeitlin PL: CFTR is a negative regulator of NFkappaB mediated innate immune response. PloS one. 2009, 4 (2): e4664-10.1371\/journal.pone.0004664.","journal-title":"PloS one"},{"issue":"17","key":"4249_CR44","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1158\/0008-5472.CAN-08-0578","volume":"68","author":"MC Markowski","year":"2008","unstructured":"Markowski MC, Bowen C, Gelmann EP: Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1. Cancer Res. 2008, 68 (17): 6896-6901. 10.1158\/0008-5472.CAN-08-0578.","journal-title":"Cancer Res"},{"issue":"9","key":"4249_CR45","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/pros.22648","volume":"73","author":"DB Shinohara","year":"2013","unstructured":"Shinohara DB, Vaghasia AM, Yu SH, Mak TN, Bruggemann H, Nelson WG, De Marzo AM, Yegnasubramanian S, Sfanos KS: A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate. 2013, 73 (9): 1007-1015. 10.1002\/pros.22648.","journal-title":"Prostate"},{"key":"4249_CR46","volume-title":"Mol Carcinog","author":"B Debelec-Butuner","year":"2012","unstructured":"Debelec-Butuner B, Alapinar C, Varisli L, Erbaykent-Tepedelen B, Hamid SM, Gonen-Korkmaz C, Korkmaz KS: Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation. Mol Carcinog. 2012 Aug 21, doi:10.1002\/mc.21948"},{"issue":"5","key":"4249_CR47","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.2353\/ajpath.2010.080747","volume":"176","author":"M Khalili","year":"2010","unstructured":"Khalili M, Mutton LN, Gurel B, Hicks JL, De Marzo AM, Bieberich CJ: Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia. The Am Jof pathology. 2010, 176 (5): 2259-2268. 10.2353\/ajpath.2010.080747.","journal-title":"The Am Jof pathology"},{"issue":"4","key":"4249_CR48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4161\/cbt.11.4.14180","volume":"11","author":"AA Mohamed","year":"2011","unstructured":"Mohamed AA, Tan SH, Sun C, Shaheduzzaman S, Hu Y, Petrovics G, Chen Y, Sesterhenn IA, Li H, Sreenath T, et al: ERG oncogene modulates prostaglandin signaling in prostate cancer cells. Cancer Biol & therapy. 2011, 11 (4): 410-417. 10.4161\/cbt.11.4.14180.","journal-title":"Cancer Biol & therapy"},{"issue":"23","key":"4249_CR49","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1038\/sj.onc.1208518","volume":"24","author":"G Petrovics","year":"2005","unstructured":"Petrovics G, Liu A, Shaheduzzaman S, Furusato B, Sun C, Chen Y, Nau M, Ravindranath L, Dobi A, Srikantan V, et al: Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene. 2005, 24 (23): 3847-3852. 10.1038\/sj.onc.1208518.","journal-title":"Oncogene"},{"issue":"1","key":"4249_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/pcan.2009.28","volume":"13","author":"K Mwamukonda","year":"2010","unstructured":"Mwamukonda K, Chen Y, Ravindranath L, Furusato B, Hu Y, Sterbis J, Osborn D, Rosner I, Sesterhenn IA, McLeod DG, et al: Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status. Prostate cancer and prostatic Dis. 2010, 13 (1): 47-51. 10.1038\/pcan.2009.28.","journal-title":"Prostate cancer and prostatic Dis"},{"issue":"2","key":"4249_CR51","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4161\/epi.2.2.4611","volume":"2","author":"E Richter","year":"2007","unstructured":"Richter E, Masuda K, Cook C, Ehrich M, Tadese AY, Li H, Owusu A, Srivastava S, Dobi A: A role for DNA methylation in regulating the growth suppressor PMEPA1 gene in prostate cancer. Epigenetics: Off J of the DNA Methylation Soc. 2007, 2 (2): 100-109. 10.4161\/epi.2.2.4611.","journal-title":"Epigenetics: Off J of the DNA Methylation Soc"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-16\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:48:39Z","timestamp":1630550919000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,13]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4249"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-16","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,13]]},"assertion":[{"value":"16 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"16"}}